Tag: Natco pharma

Natco Pharma unveils additional strengths of generic Revlimid in U.S.

Natco Pharma unveils additional strengths of generic Revlimid in U.S.

cpooldigitalLeave a Comment on Natco Pharma unveils additional strengths of generic Revlimid in U.S.

A bottle of Revlimid seen at a store in Utah. File photo | Photo Credit: Reuters Natco Pharma has launched its generic version of Celgene Corporation’s cancer drug Revlimid (lenalidomide capsules) in additional strengths in the United States. The 2.5 mg and 20 mg strengths of the prescription medicine used in adults for the treatment […]

Continue Reading
Natco Pharma gets board nod for ₹210-crore share buyback

Natco Pharma gets board nod for ₹210-crore share buyback

cpooldigitalLeave a Comment on Natco Pharma gets board nod for ₹210-crore share buyback

The promoter and promoter group’s stake, in the event of the maximum buyback, will increase from 48.82% to 49.63%. | Photo Credit: AP Natco Pharma has got the board approval for a ₹210 crore share-buyback proposal. The company said under the proposal it will take the open market route to buy back upto 30 lakh […]

Continue Reading